About Seer, Inc.
https://seer.bioSeer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials.
CEO
Omid C. Farokhzad
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 21
Ratings Snapshot
Rating : C+
Price Target
Institutional Ownership
SOFTBANK GROUP CORP.
Shares:5.14M
Value:$9.86M
SB GLOBAL ADVISERS LTD
Shares:5.14M
Value:$9.86M
SIREN, L.L.C.
Shares:4M
Value:$7.68M
Summary
Showing Top 3 of 69
About Seer, Inc.
https://seer.bioSeer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $4.12M ▲ | $21.46M ▼ | $-18.23M ▲ | -442.47% ▲ | $-0.32 ▲ | $-15.29M ▲ |
| Q2-2025 | $4.05M ▼ | $22.64M ▼ | $-19.42M ▲ | -479.49% ▼ | $-0.33 ▲ | $-17.83M ▲ |
| Q1-2025 | $4.21M ▲ | $22.79M ▼ | $-19.95M ▲ | -474.39% ▲ | $-0.34 ▲ | $-18.25M ▲ |
| Q4-2024 | $3.95M ▲ | $23.91M ▼ | $-21.74M ▼ | -550.57% ▼ | $-0.35 | $-20.04M ▲ |
| Q3-2024 | $3.94M | $26.17M | $-21.33M | -541.05% | $-0.35 | $-22.75M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $199.24M ▼ | $308.61M ▼ | $36.79M ▲ | $271.81M ▼ |
| Q2-2025 | $209.83M ▼ | $322.49M ▼ | $34.2M ▼ | $288.29M ▼ |
| Q1-2025 | $239.72M ▲ | $347.26M ▼ | $36.26M ▼ | $311.01M ▼ |
| Q4-2024 | $236.41M ▼ | $366.6M ▼ | $39.03M ▲ | $327.57M ▼ |
| Q3-2024 | $247.6M | $383.42M | $38.7M | $344.73M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-18.23M ▲ | $-7.57M ▲ | $16.6M ▲ | $-1.99M ▲ | $7.04M ▲ | $-7.85M ▲ |
| Q2-2025 | $-19.42M ▲ | $-14.66M ▼ | $7.36M ▼ | $-7.22M ▼ | $-14.51M ▼ | $-15.23M ▼ |
| Q1-2025 | $-19.95M ▲ | $-11.42M ▲ | $24.61M ▲ | $-1.5M ▼ | $11.69M ▲ | $-12.07M ▼ |
| Q4-2024 | $-21.74M ▼ | $-11.46M ▲ | $15.85M ▼ | $-1.26M ▲ | $3.13M ▼ | $-10.92M ▲ |
| Q3-2024 | $-21.33M | $-14.13M | $26.44M | $-6.64M | $5.67M | $-16.32M |
Revenue by Products
| Product | Q1-2023 | Q2-2023 | Q3-2023 | Q4-2023 |
|---|---|---|---|---|
 Grant | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Grant and Other | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Product | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Related Party | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Service | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
CEO
Omid C. Farokhzad
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 21
Ratings Snapshot
Rating : C+
Price Target
Institutional Ownership
SOFTBANK GROUP CORP.
Shares:5.14M
Value:$9.86M
SB GLOBAL ADVISERS LTD
Shares:5.14M
Value:$9.86M
SIREN, L.L.C.
Shares:4M
Value:$7.68M
Summary
Showing Top 3 of 69